[Case of branch atheromatous disease presenting capsular warning syndrome].
We report a case of branch atheromatous disease (BAD) presenting capsular warning syndrome, who subsequently showed a complete recovery by the combination therapy as described below. A 54-year-old man with untreated hypertension was admitted to our hospital because of dysarthria and right hemiplegia. The NIHSS on admission was 12 points, but his symptoms soon completely disappeared during examination. After admission administration of aspirin, heparin, atorvastatin and t-PA were started, but stereotyped episodes of dysarthria and the right hemiplegia occurred repeatedly. We added plasma expander, and he thereafter revealed no further ischemic episodes at 22 hours from admission. Over all, he had 15 times of transient ischemic attack with no lasting deficit. The DWI scan obtained 5 hours after the onset demonstrated a high-intensity region in the left putamen to corona radiata. MRA showed no significant abnormalities. He had been diagnosed as having branch atheromatous disease with capsular warning syndrome. The present case suggests that combination therapy including t-PA and plasma expander may be effective to BAD presenting capsular warning syndrome.
The Department of Neurology, Toyama University Hospital.
Yoshiharu
Y
Taguchi
Shutaro
S
Takashima
Takamasa
T
Nukui
Nobuhiro
N
Dougu
Shigeo
S
Toyoda
Kortaro
K
Tanaka
D000925:Anticoagulants / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage; D050197:Atherosclerosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000069059:Atorvastatin; D003911:Dextrans / Q000008:administration & dosage; D038524:Diffusion Magnetic Resonance Imaging; D004359:Drug Therapy, Combination; D006538:Heptanoic Acids / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D002546:Ischemic Attack, Transient / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D018810:Magnetic Resonance Angiography; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000008:administration & dosage; D012008:Recurrence; D013577:Syndrome; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
D000925:Anticoagulants; D003911:Dextrans; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin; D010959:Tissue Plasminogen Activator; D001241:Aspirin